Sputum mast cell subtypes relate to eosinophilia and corticosteroid response in asthma

European Respiratory Journal

Volumn 47, Issue 4, 2016, Pages 1123-1133

  Wang, Gang ^a,b   Baines, Katherine J ^b   Fu, Juan Juan ^a   Wood, Lisa G ^b   Simpson, Jodie L ^b   McDonald, Vanessa M ^b   Cowan, Douglas C ^c   Taylor, D Robin ^c   Cowan, Jan O ^c   Gibson, Peter G ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYPEPTIDASE A; CARBOXYPEPTIDASE A3; CHYMASE; CORTICOSTEROID; FLUTICASONE; MESSENGER RNA; TRYPTASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CMA1 PROTEIN, HUMAN; CPA3 PROTEIN, HUMAN; NITRIC OXIDE; TPSAB1 PROTEIN, HUMAN;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; BRONCHUS REACTIVITY; CONTROLLED STUDY; DRUG RESPONSE; EOSINOPHIL COUNT; EOSINOPHILIA; EXHALED NITRIC OXIDE FRACTION; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MAST CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE ASSESSMENT; RESPIRATORY TRACT PARAMETERS; SPUTUM; UPREGULATION; AGED; CYTOLOGY; DNA MICROARRAY; EOSINOPHIL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHENOTYPE; PROSPECTIVE STUDY; REGRESSION ANALYSIS; YOUNG ADULT;

ADRENAL CORTEX HORMONES; ADULT; AGED; ASTHMA; BIOMARKERS; CARBOXYPEPTIDASES A; CHYMASES; EOSINOPHILIA; EOSINOPHILS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MALE; MAST CELLS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NITRIC OXIDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SPUTUM; TRYPTASES; YOUNG ADULT;

EID: 84963995209     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01098-2015     Document Type: Article

References (37)

1. Wenzel SE. Asthma phenotypes: The evolution from clinical to molecular approaches. Nat Med 2012; 18: 716-725.
2. Simpson JL, Scott R, Boyle MJ, et al. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006; 11: 54-61.
3. Carter RJ, Bradding P. The role of mast cells in the structural alterations of the airways as a potential mechanism in the pathogenesis of severe asthma. Curr Pharm Des 17: 685-698.
4. Irani AA, Schechter NM, Craig SS, et al. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986; 83: 4464-4468.
5. Brightling CE, Bradding P, Symon FA, et al. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346: 1699-1705.
6. Dougherty RH, Sidhu SS, Raman K, et al. Accumulation of intraepithelial mast cells with a unique protease phenotype in TH2-high asthma. J Allergy Clin Immunol 2010; 125: 1046-1053.
7. Balzar S, Fajt ML, Comhair SAA, et al. Mast cell phenotype, location, and activation in severe asthma. Am J Resp Crit Care Med 2011; 183: 299-309.
8. Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 2006; 117: 1277-1284.
9. Andersson CK, Bergqvist A, Mori M, et al. Mast cell-associated alveolar inflammation in patients with atopic uncontrolled asthma. J Allergy Clin Immunol 2011; 127: 905-912.
10. Fajt ML, Wenzel SE. Mast cells, their subtypes, and relation to asthma phenotypes. Ann Am Thorac Soc 2013; 10: S158-S164.
11. Wang G, Baines KJ, Hu JJ, et al. Mast cell-based phenotypes of asthma in induced sputum samples. Respirology 2013; 18: 108.
12. Baines KJ, Simpson JL, Wood LG, et al. Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples. J Allergy Clin Immunol 2011; 127: 153-160.
13. Cowan DC, Cowan JO, Palmay R, et al. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 2010; 65: 384-390.
14. Gibson P, Wlodarczyk J, Hensley M, et al. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood. Am J Resp Crit Care Med 1998; 158: 36-41.
15. Anderson SD, Schoeffel R, Finney M. Evaluation of ultrasonically nebulised solutions for provocation testing in patients with asthma. Thorax 1983; 38: 284-291.
16. Cai Y, Carty K, Henry RL, et al. Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children. Eur Respir J 1998; 11: 848-853.
17. Cisneros C, García-Río F, Romera D, et al. Bronchial reactivity indices are determinants of health-related quality of life in patients with stable asthma. Thorax 2010; 65: 795-800.
18. Simpson JL, McElduff P, Gibson PG. Assessment and reproducibility of non-eosinophilic asthma using induced sputum. Respiration 2010; 79: 147-151.
19. Baines KJ, Simpson JL, Wood LG, et al. Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples. J Allergy Clin Immunol 2011; 127: 153-160.
20. Baines KJ, Simpson JL, Wood LG, et al. Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes. J Allergy Clin Immunol 2014; 133: 997-1007.
21. Global Initiative for Asthma. Global strategy for asthma management and prevention, 2015. http://www.ginasthma. org/documents/4 Date last accessed: May 1, 2015.
22. Potaczek DP, Michel S, Sharma V, et al. Different FCER1A polymorphisms influence IgE levels in asthmatics and non-asthmatics. Ped Allergy Immunol 2013; 24: 441-449.
23. Rajakulasingam K, Till S, Ying S, et al. Increased expression of high affinity IgE (FcϵRI) receptor-α chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma. Am J Resp Crit Care Med 1998; 158: 233-240.
24. Du J, Stankiewicz MJ, Liu Y, et al. Novel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein. J Biol Chem 2002; 277: 43481-43494.
25. Sugita M, Brenner MB. T lymphocyte recognition of human group 1 CD1 molecules: implications for innate and acquired immunity. Semin Immunol 2000; 12: 511-516.
26. Yang CY, Chen JB, Tsai TF, et al. CLEC4F is an inducible C-type lectin F4/80-positive cells and is involved in alpha-galactosylceramide presentation in liver. PLoS One 2013; 8: e65070.
27. Lee J, Kim J, Bae J, et al. Association of CACNG6 polymorphisms with aspirin-intolerance asthmatics in a Korean population. BMC Med Genet 2010; 11: 138.
28. Jin Z, Luo R, Piao X. GPR56 and its related diseases. Prog Mol Biol Transl Sci 2009; 89: 1-13.
29. Peng Y-M, van de Garde MDB, Cheng K-F, et al. Specific expression of GPR56 by human cytotoxic lymphocytes. J Leukoc Biol 2011; 90: 735-740.
30. Visekruna A, Ritter J, Scholz T, et al. Tc9 cells, a new subset of CD8+ T cells, support Th2-mediated airway inflammation. Eur J Immunol 2013; 43: 606-618.
31. Gibson PG, Saltos N, Borgas T. Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma. J Allergy Clin Immunol 2000; 105: 752-759.
32. Zanini A, Chetta A, Saetta M, et al. Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma. J Allergy Clin Immunol 2007; 120: 329-333.
33. van den Toorn LM, Prins J-B, de Jongste JC, et al. Benefit from anti-inflammatory treatment during clinical remission of atopic asthma. Respir Med 2005; 99: 779-787.
34. Bentley AM, Hamid Q, Robinson DS, et al. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Resp Crit Care Med 1996; 153: 551-556.
35. Peters MC, Mekonnen ZK, Yuan S, et al. Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. J Allergy Clin Immunol 2014; 133: 388-394.
36. Terakawa M, Tomimori Y, Goto M, et al. Eosinophil migration induced by mast cell chymase is mediated by extracellular signal-regulated kinase pathway. Biochem Biophys Res Commun 2005; 332: 969-975.
37. Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 2013; 131: 636-645.